Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children

Rita J Jeremy1, Soyeon Kim, Molly Nozyce

  • 1Pediatric Clinical Research Center, Department of Pediatrics, School of Medicine, University of California-San Francisco, 505 Parnassus Ave, San Francisco, CA 94143-0105, USA. jeremyr@peds.ucsf.edu

Pediatrics
|February 3, 2005
PubMed

Insights

HIV-infected children exhibit poorer neuropsychological functioning, especially with higher viral loads. Antiretroviral therapy improved vocabulary but not overall cognitive function, necessitating revised treatment strategies for HIV disease.

Area of Science:

  • Pediatric infectious diseases
  • Neuroimmunology
  • Clinical pharmacology

Background:

  • HIV infection in children can impact neurodevelopment.
  • Antiretroviral therapy (ART) is crucial for managing HIV but its effect on neuropsychological functioning requires further investigation.
  • Previous treatment regimens may influence outcomes after treatment changes.

Purpose of the Study:

  • To investigate neuropsychological functioning in previously treated HIV-infected children.
  • To examine the correlation between viral load and neuropsychological performance.
  • To evaluate the impact of a new treatment regimen, including protease inhibitors (PIs), on neuropsychological outcomes.

Main Methods:

  • 489 HIV-infected children (4 months to 17 years) previously treated with ART were randomized to 7 different treatment combinations (6 with PIs).
  • Neuropsychological functioning was assessed using 13 age-appropriate measures of cognitive, neurologic, and behavioral function.
  • Children were prospectively evaluated for 48 weeks, monitoring changes in neuropsychological performance and viral load.

Main Results:

  • At baseline, HIV-infected children showed poorer neuropsychological functioning compared to age-matched norms.
  • Higher viral load at baseline was associated with poorer cognitive, fine-motor, and neurologic function.
  • After 48 weeks of PI-containing therapy, only vocabulary scores significantly improved; overall neuropsychological functioning remained below norms even with undetectable viral loads.

Conclusions:

  • HIV-infected children present with significant neuropsychological deficits, exacerbated by higher viral loads.
  • Current PI-containing combination therapies show limited efficacy in restoring neuropsychological functioning.
  • Treatment strategies for pediatric HIV disease should be reevaluated to prioritize neuropsychological recovery alongside viral load suppression.
Abstract

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...